Rada Savic

Dr. Rada Savic is a Professor at the University of California, San Francisco (UCSF), Director of UCSF’s Clinical Pharmacology and Therapeutics Fellowship Program, Co-Director of the UCSF Center for TB, and a pioneering leader in drug development intelligence, leveraging data science, computational tools, and AI to accelerate and de-risk drug discovery and development to advance drug development and routine drug therapy in infectious diseases including special populations such as children and pregnant women. Dr. Savic applies innovative, quantitative, and systems pharmacology methods to propose optimized and precision dosing strategies, data-driven risk stratification algorithms, and inspires new clinical simulation tools across the infectious disease landscape. Dr. Savic’s unique expertise in data, modeling, and knowledge integration positions her at the center of many development projects where she collaborates with teams across all drug discovery and development stages. She is currently a member of the TB Drug Accelerator, a chair of A5409 (an ACTG-funded platform clinical trial for TB regimens), a member of UNITE4TB (EU-based TB clinical trial collaborative), a member of CDC-funded TB Trial Consortium, and the leader of the Preclinical Design and Clinical Translation of Regimens for TB (PReDiCTR-TB) Consortium, an international collaboration for TB Regimen Development. Recognized for her groundbreaking contributions, Dr. Savic is a Chan-Zuckerberg Biohub Investigator, and winner of the 2025 Malle Jurima-Romet Mid-Career Leadership Award. Dr. Savic, as Mulpi-PI works with all Track Leads to ensure rigor is applied to all aspects of the development of resources.